Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CARISOPRODOL vs CARMUSTINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CARISOPRODOL vs CARMUSTINE: Safety Overview

Metric CARISOPRODOL CARMUSTINE
Total FAERS Reports 2,660 3,376
Deaths Reported 1,332 781
Death Rate 50.1% 23.1%
Hospitalizations 432 873
Average Patient Age 48.1 yrs 52.0 yrs
% Female Patients 63.6% 33.8%
FDA Approval Date Approved Prior to Jan 1, 1982 Approved Prior to Jan 1, 1982
Manufacturer ScieGen Pharmaceuticals, Inc. Amneal Pharmaceuticals LLC
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription